Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Actelion Lung Drug Meets Main Goal in Pivotal Study
Actelion Lung Drug Meets Main Goal in Pivotal Study
Actelion Lung Drug Meets Main Goal in Pivotal Study
Submitted by
admin
on April 30, 2012 - 10:21am
Source:
Bloomberg
News Tags:
Actelion
macitentan
pulmonary arterial hypertension
PAH
Headline:
Actelion Lung Drug Meets Main Goal in Pivotal Study
Do Not Allow Advertisers to Use My Personal information
